X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15718) 15718
Newsletter (129) 129
Newspaper Article (83) 83
Magazine Article (29) 29
Book Chapter (8) 8
Book Review (4) 4
Dissertation (3) 3
Conference Proceeding (2) 2
Publication (2) 2
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13572) 13572
male (8233) 8233
female (7849) 7849
middle aged (6620) 6620
interferon-alpha - administration & dosage (6300) 6300
adult (6040) 6040
interferon-alpha - therapeutic use (5263) 5263
recombinant proteins (4524) 4524
interferon-alpha (4348) 4348
aged (3893) 3893
treatment outcome (3878) 3878
hepatitis c, chronic - drug therapy (3151) 3151
interferon (3116) 3116
oncology (3095) 3095
antiviral agents - therapeutic use (3022) 3022
drug therapy, combination (2992) 2992
antiviral agents - administration & dosage (2770) 2770
interferon-alpha - adverse effects (2639) 2639
gastroenterology & hepatology (2366) 2366
therapy (2316) 2316
animals (2213) 2213
ribavirin - administration & dosage (2125) 2125
hepatitis c (2002) 2002
ribavirin - therapeutic use (1862) 1862
antineoplastic combined chemotherapy protocols - therapeutic use (1694) 1694
ribavirin (1690) 1690
care and treatment (1675) 1675
immunology (1621) 1621
cancer (1609) 1609
biological response modifiers (1568) 1568
drug administration schedule (1540) 1540
polyethylene glycols - administration & dosage (1529) 1529
interferon alpha (1528) 1528
hepacivirus - genetics (1510) 1510
polyethylene glycols - therapeutic use (1439) 1439
antiviral agents - adverse effects (1405) 1405
health aspects (1393) 1393
genotype (1360) 1360
hepatitis c virus (1297) 1297
pharmacology & pharmacy (1282) 1282
mice (1249) 1249
drug therapy (1205) 1205
adolescent (1191) 1191
antineoplastic agents - therapeutic use (1185) 1185
time factors (1170) 1170
interferon alpha-2 (1097) 1097
hepatitis c - drug therapy (1089) 1089
infection (1055) 1055
dose-response relationship, drug (1054) 1054
hepatitis c, chronic - virology (1044) 1044
follow-up studies (1029) 1029
hematology (1005) 1005
research (1005) 1005
recombinant proteins - administration & dosage (999) 999
infectious diseases (997) 997
carcinoma, renal cell - drug therapy (996) 996
kidney neoplasms - drug therapy (963) 963
immunotherapy (960) 960
recombinant proteins - therapeutic use (960) 960
virology (938) 938
interferon-alpha - pharmacology (932) 932
viral load (915) 915
prognosis (893) 893
retrospective studies (893) 893
prospective studies (880) 880
analysis (876) 876
medicine & public health (872) 872
antineoplastic agents - administration & dosage (864) 864
virus-infection (864) 864
ribavirin - adverse effects (862) 862
hepatitis (853) 853
chemotherapy (828) 828
combined modality therapy (824) 824
hepacivirus - drug effects (810) 810
plus ribavirin (808) 808
combination (787) 787
aged, 80 and over (785) 785
survival (782) 782
rna, viral - blood (780) 780
risk factors (767) 767
cytokines (738) 738
young adult (720) 720
expression (714) 714
kidney neoplasms - pathology (702) 702
trial (688) 688
recurrence (681) 681
polyethylene glycols - adverse effects (675) 675
medicine, general & internal (671) 671
combination therapy (662) 662
dosage and administration (660) 660
efficacy (660) 660
renal cell carcinoma (656) 656
hepatitis c, chronic - complications (624) 624
double-blind (617) 617
sunitinib (611) 611
antineoplastic combined chemotherapy protocols - adverse effects (609) 609
hepatitis b, chronic - drug therapy (601) 601
survival analysis (601) 601
chronic hepatitis-c (589) 589
genetic aspects (586) 586
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14929) 14929
Japanese (343) 343
German (271) 271
Russian (174) 174
French (155) 155
Chinese (115) 115
Spanish (112) 112
Polish (66) 66
Portuguese (45) 45
Italian (44) 44
Hungarian (28) 28
Czech (25) 25
Korean (23) 23
Croatian (12) 12
Serbian (11) 11
Swedish (9) 9
Slovak (6) 6
Dutch (5) 5
Danish (4) 4
Hebrew (4) 4
Norwegian (4) 4
Ukrainian (4) 4
Romanian (3) 3
Arabic (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of hepatology, ISSN 0168-8278, 2015, Volume 63, Issue 6, pp. 1511 - 1522
Summary Failure to respond to the approved combinations of multiple direct-acting antiviral agents is relatively low in hepatitis C virus treatment... 
Gastroenterology and Hepatology | Daclatasvir | Simeprevir | Treatment | Resistance-associated variants | Ledipasvir | Interferon | Hepatitis C virus | Sofosbuvir | Direct-acting antivirals | Resistanceassociated variants | CHRONIC HCV | CHRONIC HEPATITIS-C | REAL-WORLD | PEGYLATED INTERFERON | DOUBLE-BLIND | GENOTYPE 1 INFECTION | INTERFERON-ALPHA 2A | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT-NAIVE PATIENTS | DACLATASVIR PLUS SOFOSBUVIR | Uridine Monophosphate - administration & dosage | Humans | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Carbamates - administration & dosage | Simeprevir - administration & dosage | Uracil - administration & dosage | Benzimidazoles - administration & dosage | Ribavirin - administration & dosage | Treatment Failure | Protease Inhibitors - administration & dosage | Fluorenes - administration & dosage | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Clinical Trials as Topic | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Interferons - administration & dosage | Drug Resistance, Viral - genetics | Anilides - administration & dosage | Sofosbuvir - administration & dosage | Uridine Monophosphate - analogs & derivatives | Macrocyclic Compounds - administration & dosage | Sulfonamides - administration & dosage | Uracil - analogs & derivatives | Development and progression | Protease inhibitors | Drug resistance | Hepatitis C | Proteases
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2014, Volume 384, Issue 9941, pp. 414 - 426
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9941, pp. 403 - 413
Journal Article
Journal of hepatology, ISSN 0168-8278, 2014, Volume 61, Issue 4, pp. 770 - 776
Background & Aims HCV requires host lipid metabolism for replication, and apolipoproteins have been implicated in the response to treatment. Methods We... 
Gastroenterology and Hepatology | Quantitative trait loci | IL28B | Lipid metabolism | Hepatitis C virus | Apolipoproteins | PARTICLES | BETA-2-GLYCOPROTEIN-I | RIBAVIRIN | PEGYLATED INTERFERON-ALPHA | LIPOPROTEIN-LIPASE | HCV INFECTION | GENETIC-VARIATION | LOW-DENSITY | SERUM-LIPIDS | GASTROENTEROLOGY & HEPATOLOGY | GENOME-WIDE ASSOCIATION | Coinfection | Hepatitis C - drug therapy | Humans | Middle Aged | Male | Viral Load | beta 2-Glycoprotein I - blood | HIV Infections - immunology | Hepatitis C - immunology | Interleukins - genetics | Ribavirin - administration & dosage | Adult | Female | Hepacivirus - physiology | Hepatitis C - complications | Hepacivirus - drug effects | Virus Replication - drug effects | Hepatitis C - genetics | Treatment Outcome | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | beta 2-Glycoprotein I - genetics | HIV Infections - complications | HIV Infections - drug therapy | Hepatitis C - physiopathology | Aged | Polymorphism, Single Nucleotide | Genetic aspects | Health aspects | beta 2-Glycoprotein I/blood | Virus Replication/drug effects | HIV Infections/immunology | HIV Infections/drug therapy | Life Sciences | beta 2-Glycoprotein I/genetic | Immunology | Hepatitis C/complications Hepatitis | Polyethylene Glycols/administration & dosage | Interferon-alpha/administration & dosage | C/physiopathology Humans | Interleukins/genetics | Hepacivirus/physiology | C/drug therapy Hepatitis | C/immunology Hepatitis | HIV Infections/complications | Ribavirin/administration & dosage | Hepacivirus/drug effects | Antiviral Agents/administration & dosage | C/genetics Hepatitis
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10032, pp. 2008 - 2016
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 7, pp. 597 - 605
Summary Background Rates of sustained virological response (SVR) to peginterferon–ribavirin are low in patients with hepatitis C virus (HCV) genotype 1 and... 
Infectious Disease | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Recombinant Proteins - adverse effects | Viral Load | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Drug Therapy, Combination - adverse effects | HIV-1 - isolation & purification | Placebos - adverse effects | Ribavirin - administration & dosage | Adult | Female | Placebos - administration & dosage | Proline - administration & dosage | Hepacivirus - isolation & purification | Double-Blind Method | Proline - analogs & derivatives | HIV Infections - virology | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Adolescent | HIV Infections - complications | Aged | Hepacivirus - classification | Interferon-alpha - adverse effects | Medical colleges | Interferon alpha | Clinical trials | HIV (Viruses) | Biological response modifiers | Ribavirin | Viral antigens | Virus diseases | Genetic aspects | Product development | Drug therapy | Hepatitis C virus | HIV infection
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 60, Issue 3, pp. 490 - 499
Journal Article